Flavia Kiweewa Matovu
Overview
Explore the profile of Flavia Kiweewa Matovu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lantz A, Matovu F, Johnson R, Isingel E, Nakalega R, Kabwigu S, et al.
J Infect Dis
. 2024 Jul;
230(6):1434-1443.
PMID: 39047063
Background: We previously reported the effect of contraception on cervical tenofovir concentrations in Ugandan women with human immunodeficiency virus (HIV). Here we explored the role of cervicovaginal cytokines and drug...
2.
3.
Matovu F, Pettifor J, Compston J
J Bone Miner Res
. 2023 Apr;
38(5):617-618.
PMID: 37068495
No abstract available.
4.
Matovu F, Kiwanuka N, Nabwana M, Scholes D, Musoke P, Fowler M, et al.
Lancet Glob Health
. 2022 Apr;
10(5):e694-e704.
PMID: 35427526
Background: Tenofovir disoproxil fumarate (TDF) and intramuscular depot medroxyprogesterone acetate (DMPA-IM) are independently associated with reduced bone mineral density (BMD). We aimed to assess the combined effects of DMPA-IM use...
5.
Matovu F, Nabwana M, Kiwanuka N, Scholes D, Isingel E, Nolan M, et al.
JBMR Plus
. 2021 Feb;
5(2):e10446.
PMID: 33615111
Most studies evaluating BMD in human immunodeficiency virus (HIV)-infected populations have focused on antiretroviral therapy (ART)-experienced patients. In this study, the association between HIV-1 and/or depot medroxyprogesterone acetate (DMPA) and...
6.
Nicol M, Eneh P, Nakalega R, Kaiser T, Kabwigu S, Isingel E, et al.
Clin Infect Dis
. 2019 May;
70(8):1717-1724.
PMID: 31131846
Background: Effective concentrations of antiretrovirals in the female genital tract (FGT) are critical for suppression of viral shedding or effective preexposure prophylaxis. The disposition of tenofovir diphosphate (TFV-DP) and emtricitabine...
7.
Wynne J, Muwawu R, Mubiru M, Kamira B, Kemigisha D, Nakyanzi T, et al.
HIV Clin Trials
. 2018 Oct;
19(5):165-171.
PMID: 30370830
Background: The success of longitudinal trials depends greatly on using effective strategies to retain participants and ensure internal validity, maintain sufficient statistical power, and provide for the generalizability of study...
8.
Matovu F, Wattanachanya L, Beksinska M, Pettifor J, Ruxrungtham K
Curr Opin HIV AIDS
. 2016 Mar;
11(3):306-25.
PMID: 27023284
Purpose Of Review: Sub-Saharan Africa and other resource-limited settings (RLS) bear the greatest burden of the HIV epidemic globally. Advantageously, the expanding access to antiretroviral therapy (ART) has resulted in...